| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Envelope Protein gp120 | 219 | 2024 | 925 | 22.280 |
Why?
|
| HIV-1 | 341 | 2024 | 6960 | 16.520 |
Why?
|
| HIV Envelope Protein gp41 | 75 | 2023 | 306 | 11.600 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 42 | 2024 | 381 | 9.860 |
Why?
|
| HIV Antibodies | 97 | 2024 | 1341 | 7.550 |
Why?
|
| Simian immunodeficiency virus | 69 | 2018 | 814 | 5.770 |
Why?
|
| Receptors, CCR5 | 67 | 2020 | 491 | 5.640 |
Why?
|
| Virus Internalization | 34 | 2024 | 504 | 4.970 |
Why?
|
| Protein Conformation | 89 | 2024 | 3956 | 4.160 |
Why?
|
| Viral Envelope Proteins | 48 | 2020 | 640 | 4.040 |
Why?
|
| Receptors, HIV | 26 | 2023 | 159 | 3.750 |
Why?
|
| Antibodies, Neutralizing | 41 | 2024 | 2011 | 3.570 |
Why?
|
| Capsid | 29 | 2017 | 435 | 3.540 |
Why?
|
| Carrier Proteins | 33 | 2016 | 4937 | 3.290 |
Why?
|
| Protein Multimerization | 23 | 2021 | 965 | 3.010 |
Why?
|
| Virus Replication | 85 | 2024 | 2458 | 2.590 |
Why?
|
| Receptors, CXCR4 | 38 | 2020 | 729 | 2.570 |
Why?
|
| Virion | 19 | 2024 | 428 | 2.510 |
Why?
|
| Glycoproteins | 23 | 2023 | 2201 | 2.430 |
Why?
|
| Capsid Proteins | 12 | 2016 | 468 | 2.370 |
Why?
|
| Membrane Fusion | 26 | 2011 | 265 | 2.310 |
Why?
|
| Molecular Mimicry | 16 | 2023 | 213 | 2.280 |
Why?
|
| HIV Infections | 82 | 2024 | 17569 | 2.190 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 22 | 2016 | 545 | 2.160 |
Why?
|
| Cell Line | 153 | 2024 | 15597 | 2.160 |
Why?
|
| Gene Products, env | 27 | 2022 | 250 | 2.150 |
Why?
|
| Neutralization Tests | 73 | 2021 | 739 | 2.020 |
Why?
|
| HIV Fusion Inhibitors | 10 | 2022 | 82 | 2.000 |
Why?
|
| Receptors, Virus | 17 | 2020 | 652 | 1.960 |
Why?
|
| Leukemia Virus, Murine | 11 | 2015 | 95 | 1.940 |
Why?
|
| Proteins | 25 | 2013 | 6009 | 1.930 |
Why?
|
| AIDS Vaccines | 20 | 2022 | 900 | 1.810 |
Why?
|
| Epitopes | 53 | 2024 | 2526 | 1.790 |
Why?
|
| Protein Binding | 73 | 2023 | 9343 | 1.720 |
Why?
|
| Cyclophilin A | 9 | 2014 | 57 | 1.690 |
Why?
|
| Retroviridae | 16 | 2010 | 846 | 1.670 |
Why?
|
| CD4-Positive T-Lymphocytes | 39 | 2021 | 4415 | 1.660 |
Why?
|
| Macaca mulatta | 56 | 2020 | 2363 | 1.630 |
Why?
|
| Ubiquitin-Protein Ligases | 40 | 2016 | 1901 | 1.590 |
Why?
|
| HIV Envelope Protein gp160 | 11 | 2024 | 96 | 1.550 |
Why?
|
| Amino Acid Sequence | 111 | 2021 | 13420 | 1.530 |
Why?
|
| Molecular Sequence Data | 118 | 2015 | 17617 | 1.420 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 14 | 2023 | 306 | 1.380 |
Why?
|
| Retroviridae Infections | 8 | 2013 | 148 | 1.380 |
Why?
|
| Indenes | 2 | 2022 | 59 | 1.350 |
Why?
|
| Guanidines | 2 | 2022 | 194 | 1.330 |
Why?
|
| HeLa Cells | 49 | 2019 | 3074 | 1.320 |
Why?
|
| Virus Attachment | 5 | 2020 | 56 | 1.320 |
Why?
|
| Protein Structure, Tertiary | 34 | 2015 | 3771 | 1.250 |
Why?
|
| Recombinant Fusion Proteins | 29 | 2014 | 3740 | 1.210 |
Why?
|
| Anti-HIV Agents | 26 | 2023 | 4573 | 1.180 |
Why?
|
| Models, Molecular | 47 | 2024 | 5402 | 1.100 |
Why?
|
| Antibodies, Viral | 19 | 2020 | 3216 | 1.080 |
Why?
|
| Disulfides | 9 | 2021 | 466 | 1.070 |
Why?
|
| Virus Uncoating | 3 | 2014 | 13 | 0.990 |
Why?
|
| Deltaretrovirus | 33 | 1987 | 162 | 0.980 |
Why?
|
| Biopolymers | 4 | 2015 | 183 | 0.950 |
Why?
|
| HEK293 Cells | 28 | 2024 | 4289 | 0.930 |
Why?
|
| Structure-Activity Relationship | 33 | 2021 | 3055 | 0.920 |
Why?
|
| Binding Sites | 45 | 2023 | 6022 | 0.900 |
Why?
|
| Dogs | 25 | 2020 | 3844 | 0.890 |
Why?
|
| Piperazines | 9 | 2020 | 2552 | 0.860 |
Why?
|
| Genes, Viral | 48 | 2007 | 655 | 0.860 |
Why?
|
| Animals | 208 | 2021 | 169222 | 0.860 |
Why?
|
| Cytoplasm | 9 | 2011 | 1505 | 0.840 |
Why?
|
| Proteolipids | 6 | 2010 | 112 | 0.790 |
Why?
|
| Antibodies, Monoclonal | 62 | 2020 | 9252 | 0.770 |
Why?
|
| Humans | 392 | 2024 | 767991 | 0.750 |
Why?
|
| Reassortant Viruses | 8 | 2004 | 36 | 0.750 |
Why?
|
| Mutagenesis, Site-Directed | 18 | 2018 | 1683 | 0.750 |
Why?
|
| Transfection | 53 | 2010 | 5757 | 0.730 |
Why?
|
| Acquired Immunodeficiency Syndrome | 23 | 2008 | 2204 | 0.720 |
Why?
|
| Drug Resistance, Viral | 2 | 2022 | 869 | 0.720 |
Why?
|
| Mutant Proteins | 4 | 2017 | 488 | 0.710 |
Why?
|
| Genes, env | 12 | 2019 | 96 | 0.700 |
Why?
|
| Viral Tropism | 4 | 2014 | 102 | 0.700 |
Why?
|
| Cold Temperature | 4 | 2017 | 791 | 0.680 |
Why?
|
| Protein Processing, Post-Translational | 14 | 2021 | 1966 | 0.680 |
Why?
|
| Antigens, Viral | 9 | 2020 | 995 | 0.650 |
Why?
|
| Moloney murine leukemia virus | 5 | 2007 | 110 | 0.650 |
Why?
|
| Membrane Glycoproteins | 13 | 2019 | 3710 | 0.630 |
Why?
|
| Species Specificity | 14 | 2013 | 2415 | 0.620 |
Why?
|
| Lentiviruses, Primate | 1 | 2018 | 7 | 0.620 |
Why?
|
| Callithrix | 5 | 2016 | 95 | 0.620 |
Why?
|
| Protein Structure, Secondary | 8 | 2014 | 1216 | 0.610 |
Why?
|
| Reverse Transcription | 4 | 2013 | 48 | 0.610 |
Why?
|
| Cross-Linking Reagents | 4 | 2019 | 693 | 0.610 |
Why?
|
| Giant Cells | 14 | 2017 | 187 | 0.600 |
Why?
|
| Amino Acid Substitution | 14 | 2017 | 1743 | 0.600 |
Why?
|
| Peptide Fragments | 29 | 2016 | 5151 | 0.600 |
Why?
|
| Recombinant Proteins | 33 | 2021 | 6515 | 0.590 |
Why?
|
| Protein Structure, Quaternary | 5 | 2014 | 426 | 0.590 |
Why?
|
| Cytopathogenic Effect, Viral | 16 | 2006 | 152 | 0.580 |
Why?
|
| Retroviridae Proteins | 18 | 2004 | 94 | 0.560 |
Why?
|
| Lipid Bilayers | 3 | 2017 | 379 | 0.560 |
Why?
|
| HIV | 22 | 2007 | 1597 | 0.540 |
Why?
|
| Nucleocapsid | 4 | 2020 | 61 | 0.540 |
Why?
|
| Receptors, Cytokine | 7 | 1997 | 258 | 0.510 |
Why?
|
| Viral Regulatory and Accessory Proteins | 11 | 2017 | 151 | 0.510 |
Why?
|
| Glycosylation | 20 | 2021 | 1100 | 0.510 |
Why?
|
| Mutation | 53 | 2022 | 30211 | 0.510 |
Why?
|
| Binding Sites, Antibody | 12 | 2010 | 340 | 0.510 |
Why?
|
| Glycopeptides | 4 | 2021 | 225 | 0.490 |
Why?
|
| Semicarbazones | 1 | 2014 | 4 | 0.480 |
Why?
|
| Cryoelectron Microscopy | 7 | 2024 | 648 | 0.480 |
Why?
|
| Viral Proteins | 24 | 2010 | 1802 | 0.470 |
Why?
|
| Polysaccharides | 6 | 2024 | 1024 | 0.470 |
Why?
|
| Haplorhini | 5 | 2016 | 523 | 0.470 |
Why?
|
| Gene Expression Regulation, Viral | 11 | 2021 | 435 | 0.470 |
Why?
|
| Ligands | 18 | 2020 | 3284 | 0.460 |
Why?
|
| Thiadiazoles | 1 | 2014 | 63 | 0.460 |
Why?
|
| Vaccines | 1 | 2023 | 842 | 0.460 |
Why?
|
| Cell Line, Transformed | 13 | 2014 | 866 | 0.460 |
Why?
|
| Point Mutation | 7 | 2006 | 1594 | 0.450 |
Why?
|
| Pyridones | 1 | 2019 | 819 | 0.450 |
Why?
|
| Base Sequence | 54 | 2013 | 12418 | 0.450 |
Why?
|
| Solubility | 15 | 2024 | 1083 | 0.450 |
Why?
|
| Epitope Mapping | 8 | 2020 | 301 | 0.450 |
Why?
|
| DNA, Viral | 23 | 2018 | 2201 | 0.450 |
Why?
|
| Amino Acid Motifs | 9 | 2017 | 930 | 0.440 |
Why?
|
| Lentivirus | 1 | 2016 | 518 | 0.440 |
Why?
|
| Infectious Anemia Virus, Equine | 1 | 2013 | 4 | 0.440 |
Why?
|
| Antiviral Agents | 6 | 2021 | 3073 | 0.430 |
Why?
|
| Detergents | 3 | 2023 | 235 | 0.430 |
Why?
|
| Saimiri | 3 | 2010 | 337 | 0.420 |
Why?
|
| Immune Evasion | 6 | 2020 | 375 | 0.420 |
Why?
|
| Protein Folding | 1 | 2017 | 871 | 0.420 |
Why?
|
| HIV-2 | 5 | 2020 | 156 | 0.410 |
Why?
|
| Dimerization | 9 | 2013 | 887 | 0.410 |
Why?
|
| Sequence Deletion | 17 | 2005 | 1494 | 0.400 |
Why?
|
| Human T-lymphotropic virus 1 | 10 | 1997 | 143 | 0.400 |
Why?
|
| Receptors, Chemokine | 8 | 2006 | 652 | 0.400 |
Why?
|
| Adaptation, Biological | 2 | 2015 | 147 | 0.390 |
Why?
|
| Mutation, Missense | 6 | 2016 | 2592 | 0.380 |
Why?
|
| Cells, Cultured | 39 | 2019 | 19017 | 0.380 |
Why?
|
| T-Lymphocytes | 35 | 2004 | 10264 | 0.370 |
Why?
|
| Avian Sarcoma Viruses | 4 | 2007 | 76 | 0.370 |
Why?
|
| Virus Integration | 2 | 2013 | 307 | 0.370 |
Why?
|
| Genetic Vectors | 12 | 2003 | 3402 | 0.370 |
Why?
|
| COS Cells | 10 | 2012 | 1135 | 0.370 |
Why?
|
| Lymphocytes | 13 | 2016 | 2614 | 0.370 |
Why?
|
| Triazoles | 5 | 2020 | 904 | 0.370 |
Why?
|
| Protein Stability | 5 | 2023 | 579 | 0.360 |
Why?
|
| Tyrosine | 8 | 2007 | 1427 | 0.360 |
Why?
|
| Host-Pathogen Interactions | 4 | 2021 | 1469 | 0.360 |
Why?
|
| Atelinae | 1 | 2010 | 1 | 0.350 |
Why?
|
| Biomimetics | 5 | 2020 | 172 | 0.350 |
Why?
|
| Spumavirus | 1 | 2010 | 17 | 0.350 |
Why?
|
| Sulfates | 6 | 2007 | 379 | 0.350 |
Why?
|
| Immunization | 8 | 2018 | 1218 | 0.330 |
Why?
|
| Sulfonamides | 1 | 2019 | 1982 | 0.330 |
Why?
|
| Epitopes, B-Lymphocyte | 5 | 2020 | 85 | 0.330 |
Why?
|
| Jurkat Cells | 8 | 2017 | 740 | 0.330 |
Why?
|
| Lymphocyte Depletion | 3 | 2001 | 605 | 0.330 |
Why?
|
| DNA Primers | 12 | 2013 | 2827 | 0.320 |
Why?
|
| Chimera | 8 | 2003 | 454 | 0.320 |
Why?
|
| Phenylalanine | 4 | 2020 | 367 | 0.320 |
Why?
|
| Immunoglobulin Fab Fragments | 13 | 2020 | 446 | 0.320 |
Why?
|
| CHO Cells | 10 | 2021 | 1379 | 0.310 |
Why?
|
| Macrophage Inflammatory Proteins | 5 | 2001 | 122 | 0.310 |
Why?
|
| Protein Interaction Domains and Motifs | 4 | 2016 | 451 | 0.310 |
Why?
|
| Protein Transport | 3 | 2021 | 1951 | 0.310 |
Why?
|
| Cell Fusion | 8 | 2013 | 294 | 0.310 |
Why?
|
| Sequence Alignment | 9 | 2014 | 2178 | 0.300 |
Why?
|
| Platyrrhini | 1 | 2007 | 5 | 0.300 |
Why?
|
| HIV Antigens | 8 | 2017 | 328 | 0.300 |
Why?
|
| Binding, Competitive | 16 | 2011 | 1142 | 0.300 |
Why?
|
| Macaca | 6 | 2014 | 413 | 0.290 |
Why?
|
| Crystallography, X-Ray | 17 | 2019 | 1951 | 0.280 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2000 | 471 | 0.280 |
Why?
|
| Thermodynamics | 8 | 2012 | 591 | 0.270 |
Why?
|
| Cell Nucleus | 6 | 2011 | 2881 | 0.270 |
Why?
|
| RNA, Viral | 21 | 2018 | 2871 | 0.270 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2006 | 40 | 0.270 |
Why?
|
| Crows | 1 | 2006 | 5 | 0.270 |
Why?
|
| Cricetulus | 9 | 2021 | 812 | 0.270 |
Why?
|
| Ethers | 1 | 2006 | 73 | 0.270 |
Why?
|
| Primates | 3 | 2016 | 520 | 0.260 |
Why?
|
| Arginine | 2 | 2007 | 932 | 0.260 |
Why?
|
| Genetic Variation | 11 | 2011 | 6611 | 0.260 |
Why?
|
| Rabbits | 9 | 2020 | 4771 | 0.250 |
Why?
|
| Polyubiquitin | 1 | 2006 | 68 | 0.250 |
Why?
|
| Peptides | 6 | 2023 | 4354 | 0.250 |
Why?
|
| Anti-Retroviral Agents | 2 | 2005 | 1789 | 0.250 |
Why?
|
| Kinetics | 14 | 2018 | 6328 | 0.250 |
Why?
|
| Proviruses | 11 | 1997 | 319 | 0.250 |
Why?
|
| DNA-Binding Proteins | 4 | 2008 | 9614 | 0.250 |
Why?
|
| Drug Design | 8 | 2019 | 1045 | 0.250 |
Why?
|
| Chemokines, CC | 3 | 2011 | 286 | 0.240 |
Why?
|
| Adaptation, Physiological | 3 | 2010 | 1311 | 0.240 |
Why?
|
| Conserved Sequence | 8 | 2016 | 1162 | 0.240 |
Why?
|
| Maleates | 1 | 2024 | 18 | 0.240 |
Why?
|
| Membrane Proteins | 8 | 2018 | 7876 | 0.240 |
Why?
|
| Chemokines | 7 | 2007 | 963 | 0.240 |
Why?
|
| Virus Activation | 6 | 2018 | 324 | 0.240 |
Why?
|
| Cytoplasmic Structures | 1 | 2004 | 21 | 0.230 |
Why?
|
| Genes, vif | 2 | 1994 | 15 | 0.230 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2003 | 1247 | 0.230 |
Why?
|
| Hot Temperature | 1 | 2010 | 1441 | 0.220 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2007 | 1319 | 0.220 |
Why?
|
| Defective Viruses | 3 | 1995 | 89 | 0.220 |
Why?
|
| Styrene | 1 | 2023 | 23 | 0.220 |
Why?
|
| Protein Subunits | 4 | 2013 | 943 | 0.220 |
Why?
|
| Macrophages | 15 | 2014 | 5799 | 0.220 |
Why?
|
| Plasmids | 26 | 1995 | 2269 | 0.210 |
Why?
|
| Virus Shedding | 2 | 2020 | 110 | 0.210 |
Why?
|
| Temperature | 7 | 2011 | 2234 | 0.210 |
Why?
|
| Gene Products, gag | 12 | 2018 | 318 | 0.210 |
Why?
|
| Aotidae | 3 | 2007 | 57 | 0.210 |
Why?
|
| Phylogeny | 7 | 2014 | 2843 | 0.210 |
Why?
|
| Green Fluorescent Proteins | 4 | 2013 | 2065 | 0.200 |
Why?
|
| Amino Acids | 7 | 2009 | 1716 | 0.200 |
Why?
|
| Cloning, Molecular | 17 | 2004 | 4168 | 0.200 |
Why?
|
| Protein Precursors | 9 | 2005 | 1134 | 0.200 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 11 | 1996 | 221 | 0.200 |
Why?
|
| Nanostructures | 2 | 2018 | 553 | 0.200 |
Why?
|
| Mutagenesis | 9 | 2005 | 1228 | 0.200 |
Why?
|
| Cysteine | 3 | 2013 | 897 | 0.200 |
Why?
|
| Disease Susceptibility | 4 | 2007 | 1793 | 0.190 |
Why?
|
| Carbohydrates | 1 | 2024 | 389 | 0.190 |
Why?
|
| Gene Transfer Techniques | 3 | 1998 | 1207 | 0.190 |
Why?
|
| Cebidae | 3 | 2005 | 21 | 0.190 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 21 | 1990 | 781 | 0.190 |
Why?
|
| Genes, nef | 3 | 1997 | 52 | 0.190 |
Why?
|
| Genes, vpr | 3 | 1996 | 19 | 0.190 |
Why?
|
| HIV Seropositivity | 4 | 2023 | 966 | 0.190 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2001 | 175 | 0.180 |
Why?
|
| Leukocytes, Mononuclear | 11 | 2004 | 1854 | 0.180 |
Why?
|
| Immunoglobulin Variable Region | 7 | 2004 | 419 | 0.180 |
Why?
|
| Evolution, Molecular | 2 | 2006 | 1896 | 0.180 |
Why?
|
| Surface Plasmon Resonance | 8 | 2013 | 272 | 0.170 |
Why?
|
| Stereoisomerism | 2 | 2019 | 612 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 9 | 2013 | 1731 | 0.170 |
Why?
|
| Molecular Weight | 9 | 2007 | 2173 | 0.170 |
Why?
|
| Antigen-Antibody Reactions | 3 | 2007 | 342 | 0.170 |
Why?
|
| Chemokine CXCL12 | 8 | 2011 | 457 | 0.170 |
Why?
|
| Polymers | 2 | 2024 | 1627 | 0.170 |
Why?
|
| Lipids | 2 | 2023 | 3342 | 0.170 |
Why?
|
| Cell Transformation, Viral | 9 | 1997 | 530 | 0.160 |
Why?
|
| Virus Latency | 2 | 2021 | 361 | 0.160 |
Why?
|
| Lactobacillus acidophilus | 1 | 2019 | 21 | 0.160 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2013 | 827 | 0.160 |
Why?
|
| Chemical Engineering | 1 | 2019 | 15 | 0.160 |
Why?
|
| Nuclear Proteins | 3 | 2008 | 5799 | 0.160 |
Why?
|
| Immunity, Innate | 3 | 2008 | 3079 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 6 | 2015 | 4785 | 0.160 |
Why?
|
| Calorimetry | 5 | 2012 | 132 | 0.160 |
Why?
|
| Antibody Specificity | 7 | 2017 | 1065 | 0.160 |
Why?
|
| Cell Death | 2 | 2003 | 1679 | 0.160 |
Why?
|
| Flow Cytometry | 9 | 2016 | 5902 | 0.160 |
Why?
|
| Gene Expression | 12 | 2016 | 7597 | 0.160 |
Why?
|
| Multiprotein Complexes | 3 | 2011 | 1110 | 0.160 |
Why?
|
| Antigens, CD | 4 | 2017 | 4035 | 0.160 |
Why?
|
| SAIDS Vaccines | 2 | 2000 | 144 | 0.150 |
Why?
|
| Glutaral | 1 | 2018 | 78 | 0.150 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2017 | 464 | 0.150 |
Why?
|
| Chemokines, CXC | 7 | 2005 | 420 | 0.150 |
Why?
|
| Gene Products, vif | 2 | 1994 | 31 | 0.150 |
Why?
|
| Precipitin Tests | 6 | 2001 | 816 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 2906 | 0.140 |
Why?
|
| Lysine | 1 | 2022 | 1000 | 0.140 |
Why?
|
| Cricetinae | 11 | 2017 | 2423 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 3 | 2013 | 2634 | 0.140 |
Why?
|
| Chemokine CCL4 | 5 | 2001 | 127 | 0.140 |
Why?
|
| Microscopy, Electron | 4 | 2013 | 2559 | 0.140 |
Why?
|
| Ribonucleoproteins | 3 | 2008 | 359 | 0.140 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2019 | 415 | 0.130 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2015 | 2748 | 0.130 |
Why?
|
| Receptors, Interleukin-2 | 7 | 1998 | 564 | 0.130 |
Why?
|
| Genes, Reporter | 3 | 2008 | 1526 | 0.130 |
Why?
|
| DNA | 8 | 2018 | 7213 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 1996 | 792 | 0.130 |
Why?
|
| Serial Passage | 3 | 2004 | 23 | 0.130 |
Why?
|
| Simplexvirus | 4 | 2010 | 805 | 0.130 |
Why?
|
| Genetic Complementation Test | 4 | 1992 | 557 | 0.130 |
Why?
|
| Gene Products, tax | 2 | 1992 | 51 | 0.130 |
Why?
|
| Molecular Probes | 1 | 2017 | 309 | 0.130 |
Why?
|
| HTLV-I Infections | 1 | 1996 | 104 | 0.130 |
Why?
|
| Recombination, Genetic | 7 | 2004 | 1525 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2018 | 1335 | 0.130 |
Why?
|
| Crystallization | 6 | 2020 | 520 | 0.130 |
Why?
|
| Virus Assembly | 1 | 1996 | 140 | 0.130 |
Why?
|
| Macromolecular Substances | 4 | 2006 | 1435 | 0.130 |
Why?
|
| Genes | 7 | 1987 | 1824 | 0.120 |
Why?
|
| Complement C3d | 2 | 2005 | 21 | 0.120 |
Why?
|
| Transcription Factors | 13 | 2010 | 12165 | 0.120 |
Why?
|
| Human Immunodeficiency Virus Proteins | 7 | 2017 | 56 | 0.120 |
Why?
|
| Nanoparticles | 2 | 2024 | 1983 | 0.120 |
Why?
|
| Antigenic Variation | 4 | 2016 | 117 | 0.120 |
Why?
|
| Models, Biological | 7 | 2016 | 9493 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 10757 | 0.120 |
Why?
|
| Immune Sera | 5 | 2000 | 605 | 0.120 |
Why?
|
| Small Molecule Libraries | 2 | 2017 | 742 | 0.120 |
Why?
|
| Protein Denaturation | 2 | 2010 | 242 | 0.120 |
Why?
|
| Circular Dichroism | 4 | 2008 | 337 | 0.110 |
Why?
|
| Oligopeptides | 3 | 2004 | 1194 | 0.110 |
Why?
|
| Radioimmunoprecipitation Assay | 4 | 1996 | 16 | 0.110 |
Why?
|
| Gene Expression Regulation | 22 | 2021 | 11930 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 8 | 2013 | 6071 | 0.110 |
Why?
|
| Entropy | 2 | 2006 | 211 | 0.110 |
Why?
|
| Cyclic AMP | 2 | 1996 | 1471 | 0.110 |
Why?
|
| Viral Fusion Proteins | 1 | 1994 | 100 | 0.110 |
Why?
|
| Cytidine Deaminase | 1 | 2015 | 249 | 0.110 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 2202 | 0.110 |
Why?
|
| Transcription, Genetic | 17 | 2009 | 7612 | 0.110 |
Why?
|
| Nervous System Diseases | 1 | 2004 | 1661 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1997 | 1134 | 0.110 |
Why?
|
| Virulence | 5 | 2005 | 1297 | 0.110 |
Why?
|
| Cyclosporine | 3 | 2006 | 777 | 0.110 |
Why?
|
| Virus Inactivation | 1 | 2013 | 19 | 0.110 |
Why?
|
| Human T-lymphotropic virus 2 | 1 | 1992 | 10 | 0.110 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2013 | 293 | 0.100 |
Why?
|
| Immunoconjugates | 1 | 2020 | 975 | 0.100 |
Why?
|
| Antibody Affinity | 4 | 2010 | 252 | 0.100 |
Why?
|
| Gene Products, tat | 8 | 1998 | 111 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 1967 | 0.100 |
Why?
|
| Transduction, Genetic | 5 | 2010 | 899 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2009 | 2487 | 0.100 |
Why?
|
| Luciferases, Renilla | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cattle | 3 | 2019 | 3819 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 806 | 0.100 |
Why?
|
| RING Finger Domains | 1 | 2011 | 7 | 0.100 |
Why?
|
| Protein Isoforms | 2 | 2009 | 1715 | 0.100 |
Why?
|
| Indans | 1 | 2012 | 92 | 0.100 |
Why?
|
| Mannose | 1 | 2011 | 122 | 0.090 |
Why?
|
| Mice | 23 | 2021 | 82024 | 0.090 |
Why?
|
| Glutamine | 1 | 2014 | 577 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 9 | 2000 | 6119 | 0.090 |
Why?
|
| HIV Core Protein p24 | 2 | 2010 | 247 | 0.090 |
Why?
|
| DNA, Recombinant | 6 | 2005 | 455 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2021 | 2627 | 0.090 |
Why?
|
| Protein Sorting Signals | 1 | 2011 | 274 | 0.090 |
Why?
|
| Selection, Genetic | 1 | 2015 | 877 | 0.090 |
Why?
|
| B-Lymphocytes | 8 | 2017 | 4791 | 0.090 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 1838 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2013 | 5024 | 0.090 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2013 | 547 | 0.090 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2010 | 16 | 0.090 |
Why?
|
| Biosensing Techniques | 4 | 2005 | 662 | 0.090 |
Why?
|
| Phenotype | 7 | 2017 | 16723 | 0.090 |
Why?
|
| HIV Protease | 1 | 2010 | 99 | 0.090 |
Why?
|
| Vaccines, DNA | 2 | 2004 | 279 | 0.080 |
Why?
|
| Hydrocarbons | 1 | 2010 | 105 | 0.080 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 2 | 2009 | 213 | 0.080 |
Why?
|
| Genes, Immunoglobulin | 3 | 2004 | 283 | 0.080 |
Why?
|
| Genes, tat | 4 | 1996 | 15 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2005 | 3813 | 0.080 |
Why?
|
| Genes, Regulator | 7 | 1989 | 373 | 0.080 |
Why?
|
| Liposomes | 2 | 2011 | 790 | 0.080 |
Why?
|
| Cameroon | 1 | 2009 | 79 | 0.080 |
Why?
|
| Thymus Gland | 3 | 2018 | 1266 | 0.080 |
Why?
|
| Cell Membrane | 6 | 2005 | 3657 | 0.080 |
Why?
|
| Models, Structural | 2 | 2002 | 340 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1605 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 874 | 0.080 |
Why?
|
| Viral Load | 3 | 2014 | 3396 | 0.080 |
Why?
|
| Genes, rev | 4 | 1996 | 13 | 0.080 |
Why?
|
| Antigens, Surface | 3 | 1989 | 1617 | 0.080 |
Why?
|
| Antibody Formation | 5 | 2005 | 1392 | 0.080 |
Why?
|
| Spodoptera | 1 | 2008 | 140 | 0.080 |
Why?
|
| Gene Products, vpr | 4 | 1996 | 33 | 0.080 |
Why?
|
| Histidine | 1 | 2009 | 301 | 0.070 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2007 | 10 | 0.070 |
Why?
|
| Indolizines | 1 | 1987 | 29 | 0.070 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 2004 | 647 | 0.070 |
Why?
|
| Antigens | 1 | 2013 | 1442 | 0.070 |
Why?
|
| Cats | 3 | 2007 | 975 | 0.070 |
Why?
|
| Cell Lineage | 2 | 2017 | 2574 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 1972 | 0.070 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2006 | 19 | 0.070 |
Why?
|
| Leukemia Virus, Bovine | 5 | 1986 | 9 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 1986 | 393 | 0.070 |
Why?
|
| Blotting, Southern | 3 | 1992 | 775 | 0.070 |
Why?
|
| Exons | 3 | 2009 | 2393 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 677 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2011 | 1008 | 0.070 |
Why?
|
| Luciferases | 2 | 2006 | 714 | 0.070 |
Why?
|
| Alkaloids | 1 | 1987 | 192 | 0.070 |
Why?
|
| Herpes Simplex | 1 | 2010 | 470 | 0.070 |
Why?
|
| Oxalates | 1 | 2006 | 99 | 0.070 |
Why?
|
| Simian virus 40 | 4 | 2004 | 292 | 0.070 |
Why?
|
| Nocodazole | 1 | 2006 | 95 | 0.070 |
Why?
|
| Receptors, CCR3 | 4 | 2001 | 62 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 5 | 1988 | 897 | 0.060 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3115 | 0.060 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3238 | 0.060 |
Why?
|
| Quinones | 1 | 2005 | 79 | 0.060 |
Why?
|
| Primate Diseases | 1 | 2005 | 15 | 0.060 |
Why?
|
| Influenza A virus | 2 | 2008 | 460 | 0.060 |
Why?
|
| Cercopithecidae | 1 | 2005 | 22 | 0.060 |
Why?
|
| Genotype | 3 | 2010 | 13042 | 0.060 |
Why?
|
| Dyneins | 1 | 2006 | 126 | 0.060 |
Why?
|
| DNA Mutational Analysis | 5 | 1995 | 4114 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 668 | 0.060 |
Why?
|
| Benzoquinones | 1 | 2005 | 198 | 0.060 |
Why?
|
| Vesicular stomatitis Indiana virus | 2 | 2002 | 93 | 0.060 |
Why?
|
| Half-Life | 1 | 2006 | 651 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 17128 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 1992 | 2846 | 0.060 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 18344 | 0.060 |
Why?
|
| Inclusion Bodies | 1 | 2006 | 278 | 0.060 |
Why?
|
| RNA-Directed DNA Polymerase | 6 | 1995 | 222 | 0.060 |
Why?
|
| Clone Cells | 4 | 2017 | 1669 | 0.060 |
Why?
|
| Tumor Virus Infections | 1 | 2007 | 437 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2019 | 9016 | 0.060 |
Why?
|
| Restriction Mapping | 4 | 1995 | 849 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 4525 | 0.060 |
Why?
|
| Lactams, Macrocyclic | 1 | 2005 | 319 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 751 | 0.050 |
Why?
|
| Cell Separation | 2 | 2017 | 1729 | 0.050 |
Why?
|
| Peptide Library | 3 | 2000 | 351 | 0.050 |
Why?
|
| Cytosol | 2 | 2006 | 887 | 0.050 |
Why?
|
| Styrenes | 1 | 2023 | 23 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2004 | 1801 | 0.050 |
Why?
|
| Apoptosis | 2 | 1996 | 9521 | 0.050 |
Why?
|
| Escherichia coli | 4 | 2011 | 4215 | 0.050 |
Why?
|
| Immunoglobulin Fragments | 3 | 2003 | 84 | 0.050 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2018 | 393 | 0.050 |
Why?
|
| Retroviridae Proteins, Oncogenic | 2 | 1996 | 74 | 0.050 |
Why?
|
| Gene Products, rex | 3 | 1992 | 6 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2012 | 3780 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2005 | 577 | 0.050 |
Why?
|
| HIV Integrase | 1 | 2004 | 122 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 422 | 0.050 |
Why?
|
| Trans-Activators | 7 | 1990 | 2857 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2002 | 125 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2006 | 750 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 797 | 0.050 |
Why?
|
| Protein Kinases | 3 | 2000 | 1610 | 0.050 |
Why?
|
| Ethiopia | 1 | 2004 | 485 | 0.050 |
Why?
|
| Macaca fascicularis | 2 | 1995 | 912 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 9 | 1990 | 5798 | 0.050 |
Why?
|
| DNA Restriction Enzymes | 6 | 1987 | 548 | 0.050 |
Why?
|
| Gene Products, rev | 6 | 1990 | 29 | 0.050 |
Why?
|
| Lymph Nodes | 4 | 2001 | 3472 | 0.050 |
Why?
|
| Antibodies | 3 | 2007 | 2421 | 0.050 |
Why?
|
| Influenza Vaccines | 1 | 2008 | 780 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 2004 | 6231 | 0.040 |
Why?
|
| Mesocricetus | 1 | 2020 | 256 | 0.040 |
Why?
|
| Autoantibodies | 1 | 1989 | 2117 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2003 | 610 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 361 | 0.040 |
Why?
|
| Chemokine CCL11 | 2 | 1997 | 128 | 0.040 |
Why?
|
| DNA Replication | 2 | 1986 | 1427 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2006 | 1505 | 0.040 |
Why?
|
| HIV Reverse Transcriptase | 2 | 1997 | 214 | 0.040 |
Why?
|
| Alleles | 2 | 2009 | 6894 | 0.040 |
Why?
|
| Genes, vpu | 2 | 1996 | 6 | 0.040 |
Why?
|
| Interleukin-2 | 4 | 1998 | 1895 | 0.040 |
Why?
|
| Lymphocyte Count | 2 | 1998 | 794 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1996 | 1057 | 0.040 |
Why?
|
| Oncogenes | 2 | 1985 | 1232 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 695 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2021 | 287 | 0.040 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 1998 | 48 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2012 | 2596 | 0.040 |
Why?
|
| Female | 20 | 2021 | 397113 | 0.040 |
Why?
|
| Chlorobenzenes | 1 | 1998 | 31 | 0.040 |
Why?
|
| Vaccines, Attenuated | 2 | 2000 | 314 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 2018 | 149 | 0.040 |
Why?
|
| Carbohydrate Conformation | 2 | 2013 | 206 | 0.040 |
Why?
|
| Receptors, CCR4 | 1 | 1998 | 77 | 0.040 |
Why?
|
| Piperidines | 1 | 2006 | 1667 | 0.040 |
Why?
|
| Hemolysin Proteins | 1 | 2018 | 113 | 0.040 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1997 | 89 | 0.040 |
Why?
|
| Glycoside Hydrolases | 1 | 1998 | 135 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 996 | 0.040 |
Why?
|
| Viral Structural Proteins | 1 | 1997 | 93 | 0.040 |
Why?
|
| Codon | 5 | 1990 | 599 | 0.040 |
Why?
|
| Naphthalenes | 1 | 1998 | 198 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2019 | 577 | 0.040 |
Why?
|
| Magnetics | 1 | 2000 | 597 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1837 | 0.030 |
Why?
|
| Infection Control | 1 | 2004 | 985 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 1996 | 85 | 0.030 |
Why?
|
| Plant Lectins | 1 | 1997 | 103 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3428 | 0.030 |
Why?
|
| Genes, pol | 1 | 1996 | 53 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 5 | 1986 | 1367 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2017 | 363 | 0.030 |
Why?
|
| Bucladesine | 1 | 1996 | 118 | 0.030 |
Why?
|
| Radioligand Assay | 2 | 2007 | 366 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2000 | 555 | 0.030 |
Why?
|
| Prostaglandins E | 1 | 1996 | 166 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 2473 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2000 | 906 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 687 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2016 | 250 | 0.030 |
Why?
|
| Virus Cultivation | 1 | 2015 | 88 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 1999 | 557 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2019 | 994 | 0.030 |
Why?
|
| Leukemia, Hairy Cell | 2 | 1987 | 82 | 0.030 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1995 | 94 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 472 | 0.030 |
Why?
|
| HIV Long Terminal Repeat | 2 | 1996 | 86 | 0.030 |
Why?
|
| Immunoglobulin G | 6 | 2005 | 4564 | 0.030 |
Why?
|
| Time Factors | 6 | 2011 | 40214 | 0.030 |
Why?
|
| Amino Acid Isomerases | 1 | 1994 | 31 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1994 | 705 | 0.030 |
Why?
|
| Complement Inactivator Proteins | 1 | 1995 | 74 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2017 | 349 | 0.030 |
Why?
|
| Viremia | 2 | 2014 | 726 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 1197 | 0.030 |
Why?
|
| Urea | 1 | 2017 | 448 | 0.030 |
Why?
|
| Tryptophan | 1 | 1997 | 482 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 1997 | 415 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1994 | 205 | 0.030 |
Why?
|
| Kidney | 3 | 2002 | 7065 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 5 | 1998 | 120 | 0.030 |
Why?
|
| Models, Animal | 1 | 2021 | 2120 | 0.030 |
Why?
|
| Methionine | 1 | 1997 | 573 | 0.030 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 6 | 1990 | 26 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3589 | 0.030 |
Why?
|
| Acetyltransferases | 5 | 1987 | 231 | 0.030 |
Why?
|
| Mast Cells | 1 | 2001 | 1405 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1997 | 854 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1995 | 289 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 1995 | 351 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 11068 | 0.030 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 149 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1998 | 667 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2000 | 1656 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 1997 | 14718 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2016 | 4648 | 0.030 |
Why?
|
| Fibroblasts | 6 | 2010 | 4176 | 0.030 |
Why?
|
| Drosophila | 2 | 2001 | 1513 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4205 | 0.030 |
Why?
|
| Tunicamycin | 3 | 2004 | 109 | 0.030 |
Why?
|
| RNA, Messenger | 12 | 1999 | 12797 | 0.030 |
Why?
|
| Glucosides | 1 | 2018 | 533 | 0.030 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 1992 | 51 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2001 | 1904 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 2005 | 540 | 0.030 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1992 | 200 | 0.030 |
Why?
|
| Superinfection | 1 | 1992 | 62 | 0.030 |
Why?
|
| Immunosorbent Techniques | 2 | 1989 | 174 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1992 | 863 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1992 | 171 | 0.020 |
Why?
|
| Interleukins | 1 | 2017 | 796 | 0.020 |
Why?
|
| Autoradiography | 2 | 1990 | 727 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2211 | 0.020 |
Why?
|
| Electrochemistry | 1 | 1992 | 145 | 0.020 |
Why?
|
| Computer Graphics | 1 | 1993 | 344 | 0.020 |
Why?
|
| Tropism | 1 | 2011 | 44 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 1995 | 738 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1995 | 812 | 0.020 |
Why?
|
| Caffeine | 1 | 1996 | 703 | 0.020 |
Why?
|
| Cytokines | 3 | 1997 | 7450 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1994 | 818 | 0.020 |
Why?
|
| Solutions | 1 | 2012 | 409 | 0.020 |
Why?
|
| Densitometry | 1 | 1991 | 151 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1992 | 513 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2010 | 16041 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1997 | 1815 | 0.020 |
Why?
|
| Zidovudine | 1 | 1992 | 625 | 0.020 |
Why?
|
| Deltaretrovirus Infections | 2 | 1987 | 25 | 0.020 |
Why?
|
| Benchmarking | 1 | 2017 | 1057 | 0.020 |
Why?
|
| Vagina | 1 | 1996 | 850 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8748 | 0.020 |
Why?
|
| Signal Transduction | 5 | 2012 | 23642 | 0.020 |
Why?
|
| Coculture Techniques | 2 | 2008 | 1340 | 0.020 |
Why?
|
| Stromal Cells | 2 | 2005 | 1336 | 0.020 |
Why?
|
| Myristic Acids | 1 | 1989 | 49 | 0.020 |
Why?
|
| Brain | 3 | 2007 | 27366 | 0.020 |
Why?
|
| Protein Biosynthesis | 3 | 1990 | 2094 | 0.020 |
Why?
|
| Dideoxyadenosine | 1 | 1989 | 9 | 0.020 |
Why?
|
| 2-Chloroadenosine | 1 | 1989 | 11 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1996 | 1405 | 0.020 |
Why?
|
| Biological Availability | 1 | 2010 | 389 | 0.020 |
Why?
|
| Deoxyadenosines | 1 | 1989 | 27 | 0.020 |
Why?
|
| Swine | 1 | 1999 | 5994 | 0.020 |
Why?
|
| Herpesvirus 2, Saimiriine | 1 | 1989 | 61 | 0.020 |
Why?
|
| Static Electricity | 2 | 2000 | 260 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 427 | 0.020 |
Why?
|
| Ovary | 3 | 1988 | 965 | 0.020 |
Why?
|
| Polyomavirus | 1 | 1990 | 235 | 0.020 |
Why?
|
| BK Virus | 1 | 1990 | 120 | 0.020 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2010 | 165 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2002 | 3914 | 0.020 |
Why?
|
| Dideoxynucleosides | 1 | 1989 | 135 | 0.020 |
Why?
|
| Stem Cells | 1 | 2001 | 3537 | 0.020 |
Why?
|
| Genome, Viral | 1 | 1992 | 674 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 433 | 0.020 |
Why?
|
| Herpesvirus 2, Human | 1 | 2010 | 191 | 0.020 |
Why?
|
| Cell Communication | 1 | 2015 | 1660 | 0.020 |
Why?
|
| Lymphocyte Activation | 3 | 1998 | 5505 | 0.020 |
Why?
|
| Male | 9 | 2021 | 364641 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4146 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2018 | 2935 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2016 | 1068 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 18062 | 0.020 |
Why?
|
| Microglia | 1 | 1997 | 1376 | 0.020 |
Why?
|
| Peptide T | 1 | 1987 | 3 | 0.020 |
Why?
|
| Chromosome Deletion | 3 | 1990 | 1384 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 1992 | 1141 | 0.020 |
Why?
|
| Poly A | 2 | 1986 | 180 | 0.020 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2007 | 72 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 1647 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 733 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 3409 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1987 | 342 | 0.020 |
Why?
|
| Cross Reactions | 2 | 1984 | 828 | 0.020 |
Why?
|
| Scorpion Venoms | 1 | 2005 | 30 | 0.020 |
Why?
|
| Receptors, Immunologic | 3 | 1987 | 1418 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2005 | 289 | 0.020 |
Why?
|
| Peptide Mapping | 2 | 2000 | 260 | 0.010 |
Why?
|
| Drug Stability | 1 | 2005 | 291 | 0.010 |
Why?
|
| Immunodominant Epitopes | 1 | 2005 | 244 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 506 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1991 | 1752 | 0.010 |
Why?
|
| Calcium | 3 | 2005 | 5794 | 0.010 |
Why?
|
| RNA Splicing | 2 | 1988 | 905 | 0.010 |
Why?
|
| Immunoglobulin Joining Region | 1 | 2004 | 37 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1995 | 4248 | 0.010 |
Why?
|
| Asparagine | 1 | 2004 | 120 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2010 | 743 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 2005 | 525 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1995 | 5314 | 0.010 |
Why?
|
| Operon | 1 | 1985 | 371 | 0.010 |
Why?
|
| Replication Origin | 1 | 2004 | 77 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1989 | 1305 | 0.010 |
Why?
|
| Introns | 1 | 2006 | 966 | 0.010 |
Why?
|
| Chromosome Mapping | 3 | 1990 | 4618 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14486 | 0.010 |
Why?
|
| Gene Deletion | 2 | 2003 | 2673 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2008 | 843 | 0.010 |
Why?
|
| Drug Synergism | 2 | 1998 | 1760 | 0.010 |
Why?
|
| DNA, Complementary | 2 | 1997 | 1989 | 0.010 |
Why?
|
| Dendritic Cells | 2 | 2011 | 2745 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2004 | 256 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 1702 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2007 | 1883 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15944 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4576 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 2004 | 426 | 0.010 |
Why?
|
| Automation | 1 | 2005 | 589 | 0.010 |
Why?
|
| Liver | 1 | 2018 | 7574 | 0.010 |
Why?
|
| Monokines | 1 | 2002 | 71 | 0.010 |
Why?
|
| Hybridomas | 1 | 2003 | 443 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2002 | 105 | 0.010 |
Why?
|
| NF-kappa B | 1 | 1991 | 2493 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 2005 | 373 | 0.010 |
Why?
|
| Leukemia | 3 | 1986 | 1519 | 0.010 |
Why?
|
| Monocytes | 2 | 2004 | 2605 | 0.010 |
Why?
|
| Lung | 1 | 2020 | 10094 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 1765 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2002 | 636 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 1983 | 273 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1984 | 899 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2004 | 1156 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 14163 | 0.010 |
Why?
|
| Adult | 7 | 2020 | 223583 | 0.010 |
Why?
|
| Down-Regulation | 2 | 1998 | 2936 | 0.010 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 2 | 1990 | 36 | 0.010 |
Why?
|
| Chromatography | 1 | 2000 | 189 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 2000 | 113 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 65364 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 298 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1983 | 506 | 0.010 |
Why?
|
| Gene Products, nef | 1 | 2000 | 102 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 998 | 0.010 |
Why?
|
| Haplotypes | 1 | 2006 | 2722 | 0.010 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 416 | 0.010 |
Why?
|
| Charybdotoxin | 1 | 1999 | 23 | 0.010 |
Why?
|
| RNA | 2 | 1995 | 2718 | 0.010 |
Why?
|
| Chlorates | 1 | 1999 | 12 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2006 | 3623 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1989 | 2428 | 0.010 |
Why?
|
| Alanine | 1 | 2002 | 614 | 0.010 |
Why?
|
| Chemokine CCL8 | 1 | 1998 | 17 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1998 | 165 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 1998 | 72 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 505 | 0.010 |
Why?
|
| Sulfotransferases | 1 | 1999 | 150 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2000 | 1310 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 1998 | 214 | 0.010 |
Why?
|
| Oligonucleotides | 2 | 1991 | 563 | 0.010 |
Why?
|
| Cell Division | 2 | 1997 | 4473 | 0.010 |
Why?
|
| Influenza, Human | 1 | 2008 | 1541 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 1999 | 657 | 0.010 |
Why?
|
| Genes, gag | 1 | 1996 | 59 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 240 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2011 | 9384 | 0.010 |
Why?
|
| Subcellular Fractions | 2 | 1988 | 526 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1996 | 224 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1998 | 660 | 0.010 |
Why?
|
| Neoplasm Proteins | 2 | 1985 | 3601 | 0.010 |
Why?
|
| Base Composition | 1 | 1995 | 291 | 0.010 |
Why?
|
| Mink | 1 | 1995 | 31 | 0.010 |
Why?
|
| Periodic Acid | 1 | 1994 | 17 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1995 | 317 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1995 | 102 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 2 | 1985 | 311 | 0.010 |
Why?
|
| Lectins | 1 | 1997 | 490 | 0.010 |
Why?
|
| Ovum | 1 | 1995 | 187 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1995 | 235 | 0.010 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1994 | 97 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 383 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 1995 | 433 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 13665 | 0.010 |
Why?
|
| Complement C3 | 1 | 1996 | 434 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 223422 | 0.010 |
Why?
|
| Xenopus | 1 | 1995 | 711 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1996 | 600 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1996 | 659 | 0.010 |
Why?
|
| Heparin | 1 | 2000 | 1636 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1892 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 13289 | 0.010 |
Why?
|
| HIV Enhancer | 1 | 1991 | 3 | 0.010 |
Why?
|
| AIDS-Related Complex | 1 | 1991 | 107 | 0.010 |
Why?
|
| RNA Probes | 1 | 1990 | 110 | 0.010 |
Why?
|
| Mammals | 1 | 1995 | 1136 | 0.010 |
Why?
|
| Myristic Acid | 1 | 1989 | 49 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 826 | 0.010 |
Why?
|
| HTLV-I Antigens | 1 | 1989 | 7 | 0.010 |
Why?
|
| Acetylgalactosamine | 1 | 1989 | 41 | 0.000 |
Why?
|
| Endoplasmic Reticulum | 1 | 1995 | 1133 | 0.000 |
Why?
|
| Leukocytes | 1 | 1997 | 2035 | 0.000 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 1361 | 0.000 |
Why?
|
| Netherlands | 1 | 1993 | 2277 | 0.000 |
Why?
|
| Aged | 1 | 2020 | 171446 | 0.000 |
Why?
|
| Galactose | 1 | 1989 | 300 | 0.000 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1987 | 30 | 0.000 |
Why?
|
| Gene Library | 1 | 1990 | 1065 | 0.000 |
Why?
|
| Computer Simulation | 1 | 2000 | 6283 | 0.000 |
Why?
|
| Poly C | 1 | 1986 | 6 | 0.000 |
Why?
|
| Interferon Type I | 1 | 1991 | 569 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1991 | 1609 | 0.000 |
Why?
|
| Transformation, Genetic | 1 | 1987 | 194 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22381 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2006 | 26420 | 0.000 |
Why?
|
| Morphogenesis | 1 | 1989 | 746 | 0.000 |
Why?
|
| Genes, Synthetic | 1 | 1985 | 88 | 0.000 |
Why?
|
| Cyanogen Bromide | 1 | 1984 | 75 | 0.000 |
Why?
|
| Cell Fractionation | 1 | 1985 | 247 | 0.000 |
Why?
|
| Acute Disease | 1 | 1995 | 7241 | 0.000 |
Why?
|
| Chiroptera | 1 | 1985 | 62 | 0.000 |
Why?
|
| Serotyping | 1 | 1984 | 331 | 0.000 |
Why?
|
| Infant | 1 | 2006 | 36534 | 0.000 |
Why?
|
| DNA Transposable Elements | 1 | 1988 | 764 | 0.000 |
Why?
|
| Manganese | 1 | 1986 | 394 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2006 | 42665 | 0.000 |
Why?
|
| Magnesium | 1 | 1986 | 815 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2011 | 81746 | 0.000 |
Why?
|
| RNA Polymerase II | 1 | 1987 | 549 | 0.000 |
Why?
|
| Rats | 2 | 1992 | 23751 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1989 | 1361 | 0.000 |
Why?
|
| Sheep | 1 | 1985 | 1451 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1983 | 2087 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1991 | 4351 | 0.000 |
Why?
|
| Child | 1 | 2006 | 80906 | 0.000 |
Why?
|
| Adolescent | 1 | 2006 | 89155 | 0.000 |
Why?
|
| Homeostasis | 1 | 1989 | 3348 | 0.000 |
Why?
|
| Cell Survival | 1 | 1986 | 5772 | 0.000 |
Why?
|
| Lymphoma | 1 | 1985 | 1897 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 1997 | 8761 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1987 | 3841 | 0.000 |
Why?
|